The Natural History of Sialidosis Type I

Recruiting Observational Study
Observational Study
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 80
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sialidosis type 1 is an autosomal recessive disorder caused by bialleic NEU1 gene mutations. Patients with sialidosis type I present variable neurological and eye dysfunction and the progression rate is variable. The goal of this protocol is to assess the neurological and ophthalmological status of these patients and characterize the clinical and laboratory abnormalities in order to determine the …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subjects must: * Genetic diagnosis of sialidosis type I * Able to tolerate a general exam and neurological exam * Able to tolerate a modest amount of blood drawing * Able to tolerate the complete electrophysiological studies * Able to tolerate the performance of ele…
Contacts

Chin-Hsien Lin, MD, PhD

886-2-23123456

chlin@ntu.edu.tw

CONTACT

Wuh-Liang Hwu, MD, PhD

886-2-23123456

CONTACT